MI
Mosaic ImmunoEngineering Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BIBEAU PAUL R, was filed 15 Apr 2009.
Mosaic ImmunoEngineering Inc.: what insiders have been doing
Mosaic ImmunoEngineering Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Mosaic ImmunoEngineering Inc. in twelve months, the latest record being from 29 January 2021.
Looking back to 2006, when coverage begins, insiders filed 43 purchases and 4 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
77
Thresholds
n/a
Buy Volume
€237,211
43 ops. · all time
Sell Volume
€20,287
4 ops. · all time
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.06
Analyst consensus
Income statement
EBITDA-US$602.1k
Net income-US$687.8k0.0% margin
Valuation
Beta-0.68
Balance sheet & cash
Total debtUS$1.7M
Free Cash Flow-US$111.4k
Profitability & ownership
ROA-1238.2%
% insiders88.7%
% institutions0.0%
Last declaration on 29 January 2021
Declarations77 total
- 1,641,252 sharesCommon StockSEC:0001683168-21-000321:0
- 1,641,252 sharesCommon StockSEC:0001683168-21-000323:0
- 570,870 sharesCommon StockSEC:0001683168-21-000323:1
- 1,641,252 sharesCommon StockSEC:0001683168-21-000322:0
- 356,794 sharesCommon StockSEC:0001683168-21-000320:0
- 75,000 shares@ US$0.10Common StockSEC:0001019687-13-001420:0
- 4,500 shares@ US$0.10Common Stock $0.00001 par valueSEC:0001019687-12-001552:0
- 48,200 shares@ US$0.10Common Stock $0.00001 par valueSEC:0001019687-12-001552:1
- 89,290 shares@ US$0.10Common Stock $0.00001 par valueSEC:0001019687-12-001533:0
- 100,000 shares@ US$0.0745Common Stock $.00001 par valueSEC:0001019687-09-004525:0
- 25,000 shares@ US$0.30Common $.00001 par valueSEC:0001019687-09-004366:0
- 100,000 shares@ US$0.095Common Stock $.00001 par valueSEC:0001019687-09-001384:0Canonical exit: 14 Jul 2009 (T+90)
- 98,000 shares@ US$0.115Common Stock $.00001 par valueSEC:0001019687-09-000352:0Canonical exit: 30 Apr 2009 (T+90)
- 2,000 shares@ US$0.11Common Stock $.00001 par valueSEC:0001019687-09-000352:1Canonical exit: 30 Apr 2009 (T+90)
- 10,000 shares@ US$0.114Common $.00001 par valueSEC:0001019687-08-005257:0Canonical exit: 23 Feb 2009 (T+90)
- 46,800 shares@ US$0.115Common $.00001 par valueSEC:0001019687-08-005257:1Canonical exit: 24 Feb 2009 (T+90)
- 30,000 shares@ US$0.114Common $.00001 par valueSEC:0001019687-08-005257:2Canonical exit: 24 Feb 2009 (T+90)
- 63,200 shares@ US$0.111Common $.00001 par valueSEC:0001019687-08-005257:3Canonical exit: 24 Feb 2009 (T+90)
- 100,000 shares@ US$0.1147Common Stock $.00001 par valueSEC:0001019687-08-005235:0Canonical exit: 19 Feb 2009 (T+90)
- 115,959 shares@ US$0.109Common $.00001 par valueSEC:0001019687-08-005205:0Canonical exit: 18 Feb 2009 (T+90)
- 64,041 shares@ US$0.11Common $.00001 par valueSEC:0001019687-08-005205:1Canonical exit: 18 Feb 2009 (T+90)
- 111,000 shares@ US$0.11Common $.00001 par valueSEC:0001019687-08-005211:0Canonical exit: 18 Feb 2009 (T+90)
- 189,000 shares@ US$0.115Common $.00001 par valueSEC:0001019687-08-005211:1Canonical exit: 18 Feb 2009 (T+90)
- 20,000 shares@ US$0.11Common $.00001 par valueSEC:0001019687-08-005211:2Canonical exit: 19 Feb 2009 (T+90)
- 80,000 shares@ US$0.115Common $.00001 par valueSEC:0001019687-08-005211:3Canonical exit: 19 Feb 2009 (T+90)
25 of 77 declarations
About Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc. is a company focused on developing immunological therapies. It concentrates on research and innovation in the field of immunotherapy to treat various diseases.
